表紙
市場調査レポート

トランスクリプトミクスの世界市場

Global Transcriptomics Market 2014-2018

発行 TechNavio (Infiniti Research Ltd.) 商品コード 307329
出版日 ページ情報 英文 91 Pages
即納可能
価格
本日の銀行送金レート: 1USD=106.12円で換算しております。
Back to Top
トランスクリプトミクスの世界市場 Global Transcriptomics Market 2014-2018
出版日: 2014年06月30日 ページ情報: 英文 91 Pages
概要

トランスクリプトミクスは、さまざまな種類の細胞または体組織のトランスクリプトーム(ゲノムから転写されるmRNAの総体)を回収・分析する作業などから成る研究です。各細胞や体組織間のさまざまな物理的・生物学的差異は遺伝子発現の多様性から生じるものですが、場合によってはこれが疾患の原因になります。したがって、病因における転写活動の解明は研究者にとって大きな力。トランスクリプトミクスの構成技術としては、マイクロアレイ、ポリメラーゼ連鎖反応(PCR)、RNA干渉(RNAi)遺伝子抑制、次世代シーケンシング(NGS)の4つがよく知られています。これらの世界市場は今後数年にわたって15.8%の複合年間成長率を示す見込み。

当レポートでは、トランスクリプトミクスの世界市場に注目し、今後の動向を用途、技術、地域(北米、欧州・中東・アフリカ、アジア太平洋地域)別に分析・予測するほか、発展の動向および課題、主要参入企業プロフィールなどの最新情報をまとめています。

第1章 エグゼクティブサマリー

第2章 略語一覧

第3章 レポートの範囲

  • 市場概要
  • 製品構成

第4章 市場調査方法

  • 市場調査プロセス
  • 取材方法

第5章 イントロダクション

第6章 市場環境

  • 市場概要
  • 市場規模および予測
  • ファイブフォース分析

第7章 市場セグメンテーション - 用途別

第8章 市場セグメンテーション - 技術別

第9章 地域別セグメンテーション

第10章 導入基準

第11章 市場成長推進要因

第12章 推進要因とその影響度

第13章 市場課題

第14章 推進要因および課題の影響度

第15章 市場動向

第16章 動向とその影響度

第17章 事業環境

  • 競合状況
    • 重要ニュース
    • M&A、契約
  • 企業分析:2013年
  • その他の有力企業

第18章 主要企業分析(重要ファクト、事業概要、収益による事業セグメンテーション、収益による製品セグメンテーション、地域別売上、事業戦略、重要情報、SWOT分析)

  • Abbott Laboratories
  • Affymetrix Inc.
  • Agilent Technologies Inc.
  • Illumina Inc.
  • F. Hoffmann La Roche Ltd.
  • Thermo Fisher Scientific Inc.

第19章 シリーズ内の関連レポート

目次
Product Code: IRTNTR3713

About Transcriptomics and its Types

Transcriptomics studies involve the collection and analysis of transcriptomes of different types of cells or tissues of organism. A transcriptome represents the set of all RNA molecules, which is a small part of the genetic code. The variation in genetic expression characterizes the extensive range of physical and biochemical differences among various cells and tissues and may lead to disease. It helps researchers to understand transcriptional activity in disease cause. Transcriptomics includes four prominent technologies: Microarrays, PCR, RNAi Gene Silencing Technology, and NGS technologies.

TechNavio's analysts forecast the Global Transcriptomics market will grow at a CAGR of 15.8 percent over the period 2013-2018.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Transcriptomics market for the period 2014-2018. To calculate the market size, the report considers revenue generated from the sales of products used for research and diagnostics. The products employed in the use microarray, PCR, NGS and RNAi techniques are considered within the scope of the report.

TechNavio's report, the Global Transcriptomics Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions with individual country-wise revenue segmentation; it also covers the Global Transcriptomics market landscape and its growth prospects in the coming years. The report also includes a share of the key vendors operating in this market.

Key Regions

  • Americas
  • EMEA
  • APAC

Key Vendors

  • Abbott Laboratories
  • Affymetrix Inc.
  • Agilent Technologies Inc.
  • F. Hoffmann-La Roche Ltd.
  • Illumina Inc.
  • Thermo Fisher Scientific Inc.

Other Prominent Vendors

  • Biological Industries Ltd.
  • Bio-Rad Laboratories Inc.
  • Cytognomix Inc.
  • Kreatech Inc.
  • Molecular Devices LLC
  • Oxford Gene Technology Ltd.
  • Qiagen N. V.
  • SciGene Corp.
  • Sigma-Aldrich Co. LLC

Key Market Driver

  • Advancement in Transcriptomics Technology

For a full, detailed list, view our report

Key Market Challenge

  • Unmet Technological Needs

For a full, detailed list, view our report

Key Market Trend

  • Comprehensive Focus on Drug Discovery and Disease Diagnosis

For a full, detailed list, view our report

Key questions answered in this report:

  • What will the market size be in 2018 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

More Information about Transcriptomics

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview
  • 06.2. Market Size and Forecast
  • 06.3. Five Forces Analysis

07. Market Segmentation by Application

08. Market Segmentation by Technology

09. Geographical Segmentation

10. Buying Criteria

11. Market Growth Drivers

12. Drivers and their Impact

13. Market Challenges

14. Impact of Drivers and Challenges

15. Market Trends

16. Trends and their Impact

17. Vendor Landscape

  • 17.1. Competitive Scenario
    • 17.1.1. Key News
    • 17.1.2. Mergers, Acquisitions and Contracts
  • 17.2. Vendor Analysis 2013
  • 17.3. Other Prominent Vendors

18. Key Vendor Analysis

  • 18.1. Abbott Laboratories
    • 18.1.1. Key Facts
    • 18.1.2. Business Overview
    • 18.1.3. Business Segmentation by Revenue 2012
    • 18.1.4. Business Segmentation by Revenue 2011 and 2012
    • 18.1.5. Sales by Geography
    • 18.1.6. Business Strategy
    • 18.1.7. Key Developments
    • 18.1.8. SWOT Analysis
    • 18.1.9. Strengths
    • 18.1.10. Weakness
    • 18.1.11. Opportunities
    • 18.1.12. Threats
  • 18.2. Affymetrix Inc.
    • 18.2.1. Key Facts
    • 18.2.2. Business Overview
    • 18.2.3. Business Segmentation
    • 18.2.4. Business Segmentation by Revenue 2013
    • 18.2.5. Business Segmentation by Revenue 2012 and 2013
    • 18.2.6. Sales by Geography
    • 18.2.7. Business Strategy
    • 18.2.8. Key Information
    • 18.2.9. SWOT Analysis
    • 18.2.10. Strengths
    • 18.2.11. Weaknesses
    • 18.2.12. Opportunities
    • 18.2.13. Threats
  • 18.3. Agilent Technologies Inc.
    • 18.3.1. Key Facts
    • 18.3.2. Business Overview
    • 18.3.3. Business Segmentation by Revenue 2013
    • 18.3.4. Business Segmentation by Revenue 2012 and 2013
    • 18.3.5. Sales by Geography
    • 18.3.6. Business Strategy
    • 18.3.7. Key Information
    • 18.3.8. SWOT Analysis
    • 18.3.9. Strengths
    • 18.3.10. Weaknesses
    • 18.3.11. Opportunities
    • 18.3.12. Threats
  • 18.4. Illumina Inc.
    • 18.4.1. Key Facts
    • 18.4.2. Business Overview
    • 18.4.3. Business Segmentation
    • 18.4.4. Sales by Geography
    • 18.4.5. Business Strategy
    • 18.4.6. Key Information
    • 18.4.7. SWOT Analysis
    • 18.4.8. Strengths
    • 18.4.9. Weaknesses
    • 18.4.10. Opportunities
    • 18.4.11. Threats
  • 18.5. F. Hoffmann La Roche Ltd.
    • 18.5.1. Key Facts
    • 18.5.2. Business Overview
    • 18.5.3. Business Segmentation
    • 18.5.4. Business Segmentation by Revenue 2012 and 2013
    • 18.5.5. Sales by Geography
    • 18.5.6. Business Strategy
    • 18.5.7. Key Information
    • 18.5.8. SWOT Analysis
    • 18.5.9. Strengths
    • 18.5.10. Weaknesses
    • 18.5.11. Opportunities
    • 18.5.12. Threats
  • 18.6. Thermo Fisher Scientific Inc.
    • 18.6.1. Key Facts
    • 18.6.2. Business Overview
    • 18.6.3. Business Segmentation by Revenue
    • 18.6.4. Product Segmentation by Revenue
    • 18.6.5. Sales by Geography
    • 18.6.6. Business Strategy
    • 18.6.7. Key Information
    • 18.6.8. SWOT Analysis
    • 18.6.9. Strengths
    • 18.6.10. Weaknesses
    • 18.6.11. Opportunities
    • 18.6.12. Threats

19. Other Reports in this Series

List of Exhibits:

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Global Transcriptomics Market 2013-2018 (US$ million)
  • Exhibit 3: Global Transcriptomics Market by Application
  • Exhibit 4: Global Transcriptomics Market by Technology 2013
  • Exhibit 5: Global Transcriptomics Market Segmentation by Technology 2013
  • Exhibit 6: Global Transcriptomics Market by Geographical Segmentation 2013
  • Exhibit 7: Abbott Laboratories: Business Segmentation by Revenue 2012
  • Exhibit 8: Abbott Laboratories: Business Segmentation by Revenue 2011 and 2012 (US$ million)
  • Exhibit 9: Abbott Laboratories: Sales by Geography 2012
  • Exhibit 10: Affymetrix Inc.: Business Segmentation 2013
  • Exhibit 11: Affymetrix, Inc. 2013: Business Segmentation by Revenue 2013
  • Exhibit 12: Affymetrix Inc.: Business Segmentation by Revenue 2012 and 2013(US$ million)
  • Exhibit 13: Affymetrix Inc.: Sales by Geography 2013
  • Exhibit 14: Agilent Technologies Inc.: Business Segmentation by Revenue 2013
  • Exhibit 15: Agilent Technologies Inc.: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
  • Exhibit 16: Agilent Technologies Inc.: Sales by Geography 2013
  • Exhibit 17: Illumina Inc.: Business Segmentation 2013
  • Exhibit 18: Illumina Inc.: Sales by Geography 2013
  • Exhibit 19: Business Segmentation of F. Hoffmann-La Roche Ltd. 2013
  • Exhibit 20: F. Hoffmann-La Roche Ltd: Business Segmentation by Revenue 2012 and 2013
  • Exhibit 21: F. Hoffmann-La Roche Ltd: Sales by Geography 2013 (Pharmaceuticals Division)
  • Exhibit 22: F. Hoffmann-La Roche Ltd: Sales by Geography 2013 (Diagnostics Division)
  • Exhibit 23: Thermo Fisher Scientific Inc.: Business Segmentation by Revenue 2013
  • Exhibit 24: Thermo Fisher Scientific Inc.: Product Segmentation by Revenue 2013
  • Exhibit 25: Thermo Fisher Scientific Inc.: Sales by Geography 2013
Back to Top